Literature DB >> 30114375

The Course of Lung Function in Middle-aged Heavy Smokers: Incidence and Time to Early Onset of Chronic Obstructive Pulmonary Disease.

Hans Petersen1, Akshay Sood2, Francesca Polverino3, Caroline A Owen3, Victor Pinto-Plata3, Bartolomé R Celli3, Yohannes Tesfaigzi1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30114375      PMCID： PMC6290951          DOI： 10.1164/rccm.201805-0861LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  8 in total

1.  Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease.

Authors:  Peter Lange; Bartolome Celli; Alvar Agustí; Gorm Boje Jensen; Miguel Divo; Rosa Faner; Stefano Guerra; Jacob Louis Marott; Fernando D Martinez; Pablo Martinez-Camblor; Paula Meek; Caroline A Owen; Hans Petersen; Victor Pinto-Plata; Peter Schnohr; Akshay Sood; Joan B Soriano; Yohannes Tesfaigzi; Jørgen Vestbo
Journal:  N Engl J Med       Date:  2015-07-09       Impact factor: 91.245

2.  New Mexican Hispanic smokers have lower odds of chronic obstructive pulmonary disease and less decline in lung function than non-Hispanic whites.

Authors:  Shannon Bruse; Akshay Sood; Hans Petersen; Yushi Liu; Shuguang Leng; Juan C Celedón; Frank Gilliland; Bartolomé Celli; Steven A Belinsky; Yohannes Tesfaigzi
Journal:  Am J Respir Crit Care Med       Date:  2011-09-08       Impact factor: 21.405

3.  At the Root: Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease.

Authors:  Fernando J Martinez; MeiLan K Han; James P Allinson; R Graham Barr; Richard C Boucher; Peter M A Calverley; Bartolome R Celli; Stephanie A Christenson; Ronald G Crystal; Malin Fagerås; Christine M Freeman; Lars Groenke; Eric A Hoffman; Mehmet Kesimer; Kostantinos Kostikas; Robert Paine; Shahin Rafii; Stephen I Rennard; Leopoldo N Segal; Renat Shaykhiev; Christopher Stevenson; Ruth Tal-Singer; Jørgen Vestbo; Prescott G Woodruff; Jeffrey L Curtis; Jadwiga A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  2018-06-15       Impact factor: 21.405

4.  The prevalence of COPD: using smoking rates to estimate disease frequency in the general population.

Authors:  P Stang; E Lydick; C Silberman; A Kempel; E T Keating
Journal:  Chest       Date:  2000-05       Impact factor: 9.410

5.  Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study.

Authors:  Bartolomé R Celli; Nicola E Thomas; Julie A Anderson; Gary T Ferguson; Christine R Jenkins; Paul W Jones; Jørgen Vestbo; Katharine Knobil; Julie C Yates; Peter M A Calverley
Journal:  Am J Respir Crit Care Med       Date:  2008-05-29       Impact factor: 21.405

6.  Disease progression in young patients with COPD: rethinking the Fletcher and Peto model.

Authors:  Pablo Sanchez-Salcedo; Miguel Divo; Ciro Casanova; Victor Pinto-Plata; Juan P de-Torres; Claudia Cote; Carlos Cabrera; Jorge Zagaceta; Roberto Rodriguez-Roisin; Javier J Zulueta; Jose Maria Marin; Bartolome Celli
Journal:  Eur Respir J       Date:  2014-04-02       Impact factor: 16.671

7.  Spirometry and health status worsen with weight gain in obese smokers but improve in normal-weight smokers.

Authors:  Akshay Sood; Hans Petersen; Paula Meek; Yohannes Tesfaigzi
Journal:  Am J Respir Crit Care Med       Date:  2014-02-01       Impact factor: 21.405

8.  Risk factors for chronic obstructive pulmonary disease in a European cohort of young adults.

Authors:  Roberto de Marco; Simone Accordini; Alessandro Marcon; Isa Cerveri; Josep M Antó; Thorarinn Gislason; Joachim Heinrich; Christer Janson; Deborah Jarvis; Nino Kuenzli; Bénédicte Leynaert; Jordi Sunyer; Cecilie Svanes; Matthias Wjst; Peter Burney
Journal:  Am J Respir Crit Care Med       Date:  2010-10-08       Impact factor: 21.405
  8 in total
  6 in total

Review 1.  Initiating drug therapy in early stage chronic obstructive pulmonary disease: does it impact the course and outcome?

Authors:  Robert M Burkes; Michael B Drummond
Journal:  Curr Opin Pulm Med       Date:  2019-03       Impact factor: 3.155

Review 2.  Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre-Chronic Obstructive Pulmonary Disease Patients: Time to Move Forward.

Authors:  Fernando J Martinez; Alvar Agusti; Bartolome R Celli; MeiLan K Han; James P Allinson; Surya P Bhatt; Peter Calverley; Sanjay H Chotirmall; Badrul Chowdhury; Patrick Darken; Carla A Da Silva; Gavin Donaldson; Paul Dorinsky; Mark Dransfield; Rosa Faner; David M Halpin; Paul Jones; Jerry A Krishnan; Nicholas Locantore; Fernando D Martinez; Hana Mullerova; David Price; Klaus F Rabe; Colin Reisner; Dave Singh; Jørgen Vestbo; Claus F Vogelmeier; Robert A Wise; Ruth Tal-Singer; Jadwiga A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  2022-02-01       Impact factor: 21.405

3.  Rationale and design of the Early Chronic Obstructive Pulmonary Disease (ECOPD) study in Guangdong, China: a prospective observational cohort study.

Authors:  Fan Wu; Yumin Zhou; Jieqi Peng; Zhishan Deng; Xiang Wen; Zihui Wang; Youlan Zheng; Heshen Tian; Huajing Yang; Peiyu Huang; Ningning Zhao; Ruiting Sun; Rongchang Chen; Pixin Ran
Journal:  J Thorac Dis       Date:  2021-12       Impact factor: 3.005

4.  New Perspectives on Chronic Obstructive Pulmonary Disease.

Authors:  Bartolome R Celli; Dave Singh; Claus Vogelmeier; Alvar Agusti
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-09-06

5.  Low FVC/TLC in Preserved Ratio Impaired Spirometry (PRISm) is associated with features of and progression to obstructive lung disease.

Authors:  Spyridon Fortis; Alejandro Comellas; Victor Kim; Richard Casaburi; John E Hokanson; James D Crapo; Edwin K Silverman; Emily S Wan
Journal:  Sci Rep       Date:  2020-03-20       Impact factor: 4.379

6.  From GOLD 0 to Pre-COPD.

Authors:  MeiLan K Han; Alvar Agusti; Bartolome R Celli; Gerard J Criner; David M G Halpin; Nicolas Roche; Alberto Papi; Robert A Stockley; Jadwiga Wedzicha; Claus F Vogelmeier
Journal:  Am J Respir Crit Care Med       Date:  2021-02-15       Impact factor: 21.405
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.